from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1091/PE_PGRS22

LFCtreatmentdescriptionclass of inhibitor

1.490

Amikacinug/mL Amikacintranslation

-0.068

Cap5-10ug/mL Capreomycintranslation

0.882

Rox10-50 ug/mL Roxithromycintranslation

0.090

SM2-5 ug/mL Streptomycintranslation

2.658

Tet5-10 ug/mL Tetracyclinetranslation

0.346

Rif0.2-5ug/mL Rifampicintranscription

-0.296

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.699

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.774

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.556

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.213

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.773

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.222

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.241

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.525

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.208

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.202

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.817

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.020

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.927

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.661

KCN5-20 ug/mL Potassium cyaniderespiration

-0.486

NaN30.2-2 mM Sodium aziderespiration

-0.062

Nigericin50 uM Nigericinrespiration

-0.374

TRC10-150 ug/mL Triclosanrespiration

-0.136

TRZ10-25 ug/mL Thioridazinerespiration

1.721

Valinomycin0.5-10 uM Valinomycinrespiration

-2.237

ZnSO42 mM ZnSO4respiration

-0.670

menadione6-10 ug/mL Menadionerespiration

-0.123

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.774

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.212

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.849

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.332

NRP_1Non-replicating persistence stage 1dosRassociated

-0.127

Amp0.2mg/mL AmpicillincellWall

-0.313

Cephalexin20-100 ug/mL CephalexincellWall

-1.400

Cerulenin0.32-5 ug/mL CerulenincellWall

0.386

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.224

EMB10-20 ug/mL EthambutolcellWall

-0.353

Eta12-40 ug/mL EthionamidecellWall

0.494

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.041

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.149

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.322

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.445

BZA0.12 mg/mL BenzamidearomaticAmides

0.358

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.799

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.354

H2O24 mM hydrogen peroxideDNAdamaging

-0.937

Levo10 ug/mL LevofloxacinDNAdamaging

-0.307

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.102

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.287

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.089

UVUV-irradiationDNAdamaging

0.516

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.652

Antimycin12.5-50 ug/mL Antimycin A?

-1.009

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.406

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.963

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.409

PA8240.2-2 ug/mL PA-824?

0.551

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.116

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.064

Verapamil50 uM Verapamil?

-0.513

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.849

methoxatin10-20 ug/mL Methoxatin?